- Scrip Originals
- Featured Topics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Chromaderm, Inc.
Private Company Edition: Omega Funds closed its seventh venture capital fund, far exceeding its $500m goal. Also, Anaveon raised a CHF110m ($119.8m) series B round, Ambys brought its series A total to $107m with $47m in additional investment and Mythic launched with a $103m series B round.